Bradley L Campbell Amicus Therapeutics, Inc. (FOLD) insider trading activity

Bradley L Campbell is President and CEO of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 1.14 Million shares of FOLD, which is worth approximately $10.2 Million. The most recent transaction as insider was on Mar 01, 2021, when has been sold 10,514 shares (Common Stock) at a price of $11.84 per share, resulting in proceeds of $124,486. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M

28.27% 3M change

28.27% 12M change

Total Value Held $10.2 Million

Bradley L Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 01 2021	SELL Open market or private sale	$124,486 $11.84 p/Share	10,514 Reduced 2.7%	378,857 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$67,815 $6.45 p/Share	10,514 Added 2.63%	389,371 Common Stock
Feb 01 2021	SELL Open market or private sale	$200,607 $19.08 p/Share	10,514 Reduced 2.7%	378,857 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$67,815 $6.45 p/Share	10,514 Added 2.63%	389,371 Common Stock
Jan 15 2021	SELL Payment of exercise price or tax liability	$315,872 $21.84 p/Share	14,463 Reduced 3.68%	378,857 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	29,367 Added 6.95%	393,320 Common Stock
Jan 04 2021	SELL Open market or private sale	$233,095 $22.17 p/Share	10,514 Reduced 3.32%	306,333 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$67,815 $6.45 p/Share	10,514 Added 3.21%	316,847 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	57,620 Added 13.67%	363,953 Common Stock
Jan 03 2021	SELL Payment of exercise price or tax liability	$322,660 $23.09 p/Share	13,974 Reduced 4.36%	306,333 Common Stock
Jan 02 2021	SELL Payment of exercise price or tax liability	$621,306 $23.09 p/Share	26,908 Reduced 7.75%	320,307 Common Stock
Dec 31 2020	SELL Payment of exercise price or tax liability	$175,877 $23.09 p/Share	7,617 Reduced 2.15%	347,215 Common Stock
Dec 15 2020	SELL Payment of exercise price or tax liability	$113,574 $23.86 p/Share	4,760 Reduced 1.32%	354,832 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$112,888 $5.42 p/Share	20,828 Added 5.48%	359,592 Common Stock
Dec 01 2020	SELL Open market or private sale	$564,309 $22.77 p/Share	24,783 Reduced 6.82%	338,764 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$62,453 $2.52 p/Share	24,783 Added 6.38%	363,547 Common Stock
Nov 02 2020	SELL Open market or private sale	$442,854 $17.87 p/Share	24,782 Reduced 6.82%	338,764 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$62,451 $2.52 p/Share	24,782 Added 6.38%	363,546 Common Stock
Sep 28 2020	SELL Open market or private sale	$344,222 $13.89 p/Share	24,782 Reduced 6.82%	338,764 Common Stock
Sep 28 2020	BUY Exercise of conversion of derivative security	$62,451 $2.52 p/Share	24,782 Added 6.38%	363,546 Common Stock

BLC

Bradley L Campbell

President and CEO

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account